PET in abdominal pathology: advantages and limitations
- 30 January 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Abdominal Radiology
- Vol. 31 (2), 174-181
- https://doi.org/10.1007/s00261-005-0384-7
Abstract
New oncologic procedures are currently more focused on the biological features of tumors. The ideal objective is the administration of personalized effective treatments for each patient that affects not just the location and spread of disease but also special metabolic characteristics of tumoral cells. Radiologic diagnostic methods are extremely important in the management of the patient for staging, restaging, and evaluation of treatment response, and clinicians are avid for some additional functional and metabolic information. Further, they need more dynamic methods for follow-up. Nuclear Medicine and positron emission tomography (PET) in many cases can meet this requirement, although it is not perfect, at least at the present time. Currently 2-(18F)fluoro-2-desoxi-D-glucose positron emission tomography is being widely used for oncologic purposes. Its information can be very useful in abdominal diseases and must be taken into account with the results of radiologic imaging. Thus, many changes in the choice of treatment are seen. However, it is very important to know that sometimes there is a lack of specificity that has to be considered.Keywords
This publication has 46 references indexed in Scilit:
- FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- The role of positron emission tomography in radiation treatment planningSeminars in Nuclear Medicine, 2004
- Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imagingSeminars in Nuclear Medicine, 2004
- Incremental Benefits of FDG Positron Emission Tomography over CT Alone for the Preoperative Staging of Ovarian CancerAmerican Journal of Roentgenology, 2004
- Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinomaClinical Nephrology, 2003
- Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography—clinical use, interpretation methods, diagnostic improvementsSeminars in Nuclear Medicine, 2003
- Efficiency of [ 18 F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Detection of Pelvic Lymph Node Metastases in Gynecologic MalignancyAmerican Journal of Roentgenology, 2001
- Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-d-glucose PETRadiology, 1999
- Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign VariantsRadioGraphics, 1999